index  
coursenewsroomcompanycontactlogin
 
  Normal Pressure Hydrocephalus
  NPH Pathophysiology and Diagnosis
  Treatment
  Clinical outcome of NPH shunting
  Drainage rates of the elderly
  Support for the "Pin in seat" flow control technology
  The Integra NPH Low Flow Valve
  Bibliography
   

Integra NPH™ Low Flow Valve
Previous Previous | Next Next


Mature patients over sixty, exhibiting gait disturbance, dementia and urinary incontinence may not be suffering from Alzheimer's or other neurodegenerative disorders, but from Normal Pressure Hydrocephalus (NPH). The cause of this debilitating condition is unclear, but many clinicians cite an abnormal accumulation of CSF that dilates and enlarges the ventricles, unnaturally stretching delicate cerebral nerve tissue. NPH does not measurably increase ICP, so unlike most hydrocephalus, it can easily go undetected.

The Only Known Treatment
Though the cause of NPH is not clear, the best way to treat it is with a surgically implanted shunt. To date, shunts are the only known effective treatment option for NPH.

If you have questions regarding the INTEGRA NPH™ low flow valve or its use, please call one of our technical representatives at 1-800-654-2873, (Outside USA) 609-275-0500.

For product information please click here.

 
Previous Previous | Next Next

© Copyright 2004 - 2007 Integra LifeSciences Corporation. All Rights Reserved.
Integra NPH™ Low Flow valve is a trademark of Integra LifeSciences Corporation.
The Integra Wave Logo is a trademark of Integra LifeSciences Corporation.

Terms of Use • Privacy Policy